COMP <GO>
CDW vs PG // RSI-14 & 200D SMA MOMENTUM
CDW Corporation (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CDW 5
— PG 10
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PG
LAST: $153.79 (-6.91%) • MKT CAP: $20.65B
rsi-technicals
51.8
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
rsi-technicals
62.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDW VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CDW | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.70% | 51.20% | -29.50 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.80% | 25.40% | -5.60 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.0x | 16.2x | -2.20 | CDW | /valuation <GO> |
| Free Cash Flow Yield | 5.27% | 3.77% | +1.50 | CDW | /fcf-yield <GO> |
| Operating Margin | 7.40% | 24.30% | -16.90 | PG | /operating-margins <GO> |
| Net Profit Margin | 4.80% | 19.00% | -14.20 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 6.80% | 0.30% | +6.50 | CDW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.59% | 2.65% | -1.06 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.33 | 5.59 | -2.26 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.50% | +0.10 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 51.8 | 62.7 | -10.88 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.87 | +0.03 | CDW | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 21.7x | -3.70 | CDW | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.65B | $372.21B | -$351.56B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CDW REV | PG REV | CDW GROSS % | PG GROSS % | CDW FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $22.42B | $84.28B | 21.7% | 51.2% | $1.09B | $14.04B |
| FY 2024 | $21.00B | $84.04B | 21.9% | 51.4% | $1.15B | $16.52B |
| FY 2023 | $21.38B | $82.01B | 44.0% | 44.0% | $636.8M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDW // BETA 0.90
PG // BETA 0.87